OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
α‐Synuclein oligomers and clinical implications for Parkinson disease
Lorraine V. Kalia, Suneil K. Kalia, Pamela J. McLean, et al.
Annals of Neurology (2012) Vol. 73, Iss. 2, pp. 155-169
Open Access | Times Cited: 278
Lorraine V. Kalia, Suneil K. Kalia, Pamela J. McLean, et al.
Annals of Neurology (2012) Vol. 73, Iss. 2, pp. 155-169
Open Access | Times Cited: 278
Showing 1-25 of 278 citing articles:
Parkinson's disease
Lorraine V. Kalia, Anthony E. Lang
The Lancet (2015) Vol. 386, Iss. 9996, pp. 896-912
Closed Access | Times Cited: 4864
Lorraine V. Kalia, Anthony E. Lang
The Lancet (2015) Vol. 386, Iss. 9996, pp. 896-912
Closed Access | Times Cited: 4864
Ageing and Parkinson's disease: Why is advancing age the biggest risk factor?
Amy K. Reeve, Eve M. Simcox, Douglass M. Turnbull
Ageing Research Reviews (2014) Vol. 14, pp. 19-30
Open Access | Times Cited: 849
Amy K. Reeve, Eve M. Simcox, Douglass M. Turnbull
Ageing Research Reviews (2014) Vol. 14, pp. 19-30
Open Access | Times Cited: 849
Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease
Fabio A. Zucca, Juan Segura‐Aguilar, Emanuele Ferrari, et al.
Progress in Neurobiology (2015) Vol. 155, pp. 96-119
Open Access | Times Cited: 582
Fabio A. Zucca, Juan Segura‐Aguilar, Emanuele Ferrari, et al.
Progress in Neurobiology (2015) Vol. 155, pp. 96-119
Open Access | Times Cited: 582
Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis in the Last Decade
Masha G. Savelieff, Geewoo Nam, Juhye Kang, et al.
Chemical Reviews (2018) Vol. 119, Iss. 2, pp. 1221-1322
Closed Access | Times Cited: 482
Masha G. Savelieff, Geewoo Nam, Juhye Kang, et al.
Chemical Reviews (2018) Vol. 119, Iss. 2, pp. 1221-1322
Closed Access | Times Cited: 482
Protective and toxic roles of dopamine in Parkinson's disease
Juan Segura‐Aguilar, Irmgard Paris, Patricia Muñoz, et al.
Journal of Neurochemistry (2014) Vol. 129, Iss. 6, pp. 898-915
Closed Access | Times Cited: 439
Juan Segura‐Aguilar, Irmgard Paris, Patricia Muñoz, et al.
Journal of Neurochemistry (2014) Vol. 129, Iss. 6, pp. 898-915
Closed Access | Times Cited: 439
Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid
Mohammad Shahnawaz, Takahiko Tokuda, Masaaki Waragai, et al.
JAMA Neurology (2016) Vol. 74, Iss. 2, pp. 163-163
Open Access | Times Cited: 387
Mohammad Shahnawaz, Takahiko Tokuda, Masaaki Waragai, et al.
JAMA Neurology (2016) Vol. 74, Iss. 2, pp. 163-163
Open Access | Times Cited: 387
Targeting voltage-gated calcium channels in neurological and psychiatric diseases
Gerald W. Zamponi
Nature Reviews Drug Discovery (2015) Vol. 15, Iss. 1, pp. 19-34
Open Access | Times Cited: 351
Gerald W. Zamponi
Nature Reviews Drug Discovery (2015) Vol. 15, Iss. 1, pp. 19-34
Open Access | Times Cited: 351
Autophagy in neurodegenerative diseases: pathogenesis and therapy
Fang Guo, Xinyao Liu, Huaibin Cai, et al.
Brain Pathology (2017) Vol. 28, Iss. 1, pp. 3-13
Open Access | Times Cited: 336
Fang Guo, Xinyao Liu, Huaibin Cai, et al.
Brain Pathology (2017) Vol. 28, Iss. 1, pp. 3-13
Open Access | Times Cited: 336
Clinical Correlations With Lewy Body Pathology inLRRK2-Related Parkinson Disease
Lorraine V. Kalia, Anthony E. Lang, Lili‐Naz Hazrati, et al.
JAMA Neurology (2014) Vol. 72, Iss. 1, pp. 100-100
Open Access | Times Cited: 321
Lorraine V. Kalia, Anthony E. Lang, Lili‐Naz Hazrati, et al.
JAMA Neurology (2014) Vol. 72, Iss. 1, pp. 100-100
Open Access | Times Cited: 321
Extracellular α-synuclein—a novel and crucial factor in Lewy body diseases
He-Jin Lee, Eun-Jin Bae, Seung‐Jae Lee
Nature Reviews Neurology (2014) Vol. 10, Iss. 2, pp. 92-98
Closed Access | Times Cited: 277
He-Jin Lee, Eun-Jin Bae, Seung‐Jae Lee
Nature Reviews Neurology (2014) Vol. 10, Iss. 2, pp. 92-98
Closed Access | Times Cited: 277
The prion hypothesis in Parkinson's disease: Braak to the future
Naomi P. Visanji, Patricia L. Brooks, Lili‐Naz Hazrati, et al.
Acta Neuropathologica Communications (2013) Vol. 1, Iss. 1
Open Access | Times Cited: 250
Naomi P. Visanji, Patricia L. Brooks, Lili‐Naz Hazrati, et al.
Acta Neuropathologica Communications (2013) Vol. 1, Iss. 1
Open Access | Times Cited: 250
Transfer of human α-synuclein from the olfactory bulb to interconnected brain regions in mice
Nolwen L. Rey, Géraldine Petit, Luc Bousset, et al.
Acta Neuropathologica (2013) Vol. 126, Iss. 4, pp. 555-573
Open Access | Times Cited: 243
Nolwen L. Rey, Géraldine Petit, Luc Bousset, et al.
Acta Neuropathologica (2013) Vol. 126, Iss. 4, pp. 555-573
Open Access | Times Cited: 243
Disease‐modifying strategies for Parkinson's disease
Lorraine V. Kalia, Suneil K. Kalia, Anthony E. Lang
Movement Disorders (2015) Vol. 30, Iss. 11, pp. 1442-1450
Closed Access | Times Cited: 231
Lorraine V. Kalia, Suneil K. Kalia, Anthony E. Lang
Movement Disorders (2015) Vol. 30, Iss. 11, pp. 1442-1450
Closed Access | Times Cited: 231
The role of the LRRK2 gene in Parkinsonism
Jieqiong Li, Lan Tan, Jin‐Tai Yu
Molecular Neurodegeneration (2014) Vol. 9, Iss. 1
Open Access | Times Cited: 224
Jieqiong Li, Lan Tan, Jin‐Tai Yu
Molecular Neurodegeneration (2014) Vol. 9, Iss. 1
Open Access | Times Cited: 224
Cellular, molecular, and clinical mechanisms of action of deep brain stimulation—a systematic review on established indications and outlook on future developments
Martin Jakobs, Anton Fomenko, Andrés M. Lozano, et al.
EMBO Molecular Medicine (2019) Vol. 11, Iss. 4
Open Access | Times Cited: 182
Martin Jakobs, Anton Fomenko, Andrés M. Lozano, et al.
EMBO Molecular Medicine (2019) Vol. 11, Iss. 4
Open Access | Times Cited: 182
Cell death in the pathogenesis of systemic lupus erythematosus and lupus nephritis
Pragnesh Mistry, Mariana J. Kaplan
Clinical Immunology (2016) Vol. 185, pp. 59-73
Open Access | Times Cited: 177
Pragnesh Mistry, Mariana J. Kaplan
Clinical Immunology (2016) Vol. 185, pp. 59-73
Open Access | Times Cited: 177
The Threshold Theory for Parkinson's Disease
Simone Engelender, Ole Isacson
Trends in Neurosciences (2016) Vol. 40, Iss. 1, pp. 4-14
Closed Access | Times Cited: 176
Simone Engelender, Ole Isacson
Trends in Neurosciences (2016) Vol. 40, Iss. 1, pp. 4-14
Closed Access | Times Cited: 176
Ca2+ is a key factor in α-synuclein-induced neurotoxicity
Plamena R. Angelova, Marthe H. R. Ludtmann, Mathew H. Horrocks, et al.
Journal of Cell Science (2016) Vol. 129, Iss. 9, pp. 1792-1801
Open Access | Times Cited: 171
Plamena R. Angelova, Marthe H. R. Ludtmann, Mathew H. Horrocks, et al.
Journal of Cell Science (2016) Vol. 129, Iss. 9, pp. 1792-1801
Open Access | Times Cited: 171
Alpha-Synuclein Physiology and Pathology: A Perspective on Cellular Structures and Organelles
Luis Daniel Bernal-Conde, Rodrigo Ramos-Acevedo, Mario A. Reyes-Hernández, et al.
Frontiers in Neuroscience (2020) Vol. 13
Open Access | Times Cited: 161
Luis Daniel Bernal-Conde, Rodrigo Ramos-Acevedo, Mario A. Reyes-Hernández, et al.
Frontiers in Neuroscience (2020) Vol. 13
Open Access | Times Cited: 161
Mesenchymal stem cell secretome and extracellular vesicles for neurodegenerative diseases: Risk-benefit profile and next steps for the market access
Lorella Giovannelli, Elia Bari, Claudio Jommi, et al.
Bioactive Materials (2023) Vol. 29, pp. 16-35
Open Access | Times Cited: 49
Lorella Giovannelli, Elia Bari, Claudio Jommi, et al.
Bioactive Materials (2023) Vol. 29, pp. 16-35
Open Access | Times Cited: 49
Functional role of mesenchymal stem cells in the treatment of chronic neurodegenerative diseases
Debora Lo Furno, Giuliana Mannino, Rosario Giuffrida
Journal of Cellular Physiology (2017) Vol. 233, Iss. 5, pp. 3982-3999
Closed Access | Times Cited: 154
Debora Lo Furno, Giuliana Mannino, Rosario Giuffrida
Journal of Cellular Physiology (2017) Vol. 233, Iss. 5, pp. 3982-3999
Closed Access | Times Cited: 154
Pathogenesis-Targeted, Disease-Modifying Therapies in Parkinson Disease
Amaal AlDakheel, Lorraine V. Kalia, Anthony E. Lang
Neurotherapeutics (2013) Vol. 11, Iss. 1, pp. 6-23
Open Access | Times Cited: 144
Amaal AlDakheel, Lorraine V. Kalia, Anthony E. Lang
Neurotherapeutics (2013) Vol. 11, Iss. 1, pp. 6-23
Open Access | Times Cited: 144
Adaptive Cellular Stress Pathways as Therapeutic Targets of Dietary Phytochemicals: Focus on the Nervous System
Jaewon Lee, Dong‐Gyu Jo, Daeui Park, et al.
Pharmacological Reviews (2014) Vol. 66, Iss. 3, pp. 815-868
Open Access | Times Cited: 144
Jaewon Lee, Dong‐Gyu Jo, Daeui Park, et al.
Pharmacological Reviews (2014) Vol. 66, Iss. 3, pp. 815-868
Open Access | Times Cited: 144
Structural and functional properties of prefibrillar α-synuclein oligomers
Laura Pieri, Karine Madiona, Ronald Melki
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 135
Laura Pieri, Karine Madiona, Ronald Melki
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 135
Therapeutic prospects for Parkinson disease
C. Warren Olanow, Anthony H.V. Schapira
Annals of Neurology (2013) Vol. 74, Iss. 3, pp. 337-347
Closed Access | Times Cited: 133
C. Warren Olanow, Anthony H.V. Schapira
Annals of Neurology (2013) Vol. 74, Iss. 3, pp. 337-347
Closed Access | Times Cited: 133
